+Susen Rogen

Friday, 27 September 2013

Cambodia and Laos Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports
 
Complimentary Downloads

7 Days of Complimentary Downloads: 100,000+ Motion Backgrounds, Video Clips, Production Music Tracks, Sound Effects, Special Effects and More.
From our sponsors
Cambodia and Laos Pharmaceuticals and Healthcare Report Q4 2013
Sep 25th 2013, 00:00, by swapnil

BMI View: Given the small pharmaceutical market size coupled with the low per-capita pharmaceutical and healthcare spending, it is unlikely that Cambodia will present much opportunities over the medium term, although inexpensive generic drug players from countries such as India and Pakistan will benefit from this low expenditure market. We stress that extensive bureaucracy, rampant corruption and counterfeiting of pharmaceutical products remain as key threat in boosting healthcare provision. Headline Expenditure Projections ? Pharmaceuticals: KHR721.1bn (US$170mn) in 2012 to KHR789.3bn (US$190mn) in 2013; +9.5% in local currency terms and +8.2% in US dollar terms. Forecast broadly in line with Q313. …

Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=117417.

Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/cambodia-and-laos-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment